Literature DB >> 19770816

Tracking dynamics of muscle engraftment in small animals by in vivo fluorescent imaging.

Zhong Yang1, Qing Zeng, Zhiyuan Ma, Yaming Wang, Xiaoyin Xu.   

Abstract

Muscular dystrophies are a group of degenerative muscle diseases characterized by progressive loss of contractile muscle cells. Currently, there is no curative treatment available. Recent advances in stem cell biology have generated new hopes for the development of effective cell based therapies to treat these diseases. Transplantation of various types of stem cells labeled with fluorescent proteins into muscles of dystrophic animal models has been used broadly in the field. A non-invasive technique with the capability to track the transplanted cell fate longitudinally can further our ability to evaluate muscle engraftment by transplanted cells more accurately and efficiently. In the present study, we demonstrate that in vivo fluorescence imaging is a sensitive and reliable method for tracking transplanted GFP (Green Fluorescent Protein)-labeled cells in mouse skeletal muscles. Despite the concern about background due to the use of an external light necessary for excitation of fluorescent protein, we found that by using either nude mouse or eliminating hair with hair removal reagents much of this problem is eliminated. Using a CCD camera, the fluorescent signal can be detected in the tibialis anterior (TA) muscle after injection of 5 x 10(5) cells from either GFP transgenic mice or eGFP transduced myoblast culture. For more superficial muscles such as the extensor digitorum longus (EDL), injection of fewer cells produces a detectable signal. Signal intensity can be measured and quantified as the number of emitted photons per second in a region of interest (ROI). Since the acquired images show clear boundaries demarcating the engrafted area, the size of the ROI can be measured as well. If the legs are positioned consistently every time, the changes in total number of photons per second per muscle and the size of the ROI reflect the changes in the number of engrafted cells and the size of the engrafted area. Therefore the changes in the same muscle over time are quantifiable. In vivo fluorescent imaging technique has been used primarily to track the growth of tumorogenic cells, our study shows that it is a powerful tool that enables us to track the fate of transplanted stem cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19770816      PMCID: PMC3150052          DOI: 10.3791/1388

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

1.  Three-dimensional fluorescence enhanced optical tomography using referenced frequency-domain photon migration measurements at emission and excitation wavelengths.

Authors:  Jangwoen Lee; Eva M Sevick-Muraca
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2002-04       Impact factor: 2.129

Review 2.  Fluorescence molecular imaging of small animal tumor models.

Authors:  E E Graves; R Weissleder; V Ntziachristos
Journal:  Curr Mol Med       Date:  2004-06       Impact factor: 2.222

3.  The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation.

Authors:  G R Coulton; J E Morgan; T A Partridge; J C Sloper
Journal:  Neuropathol Appl Neurobiol       Date:  1988 Jan-Feb       Impact factor: 8.090

4.  Green fluorescent protein as a marker for gene expression.

Authors:  M Chalfie; Y Tu; G Euskirchen; W W Ward; D C Prasher
Journal:  Science       Date:  1994-02-11       Impact factor: 47.728

5.  Determinants of skeletal muscle contributions from circulating cells, bone marrow cells, and hematopoietic stem cells.

Authors:  Richard I Sherwood; Julie L Christensen; Irving L Weissman; Amy J Wagers
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

Review 6.  Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.

Authors:  Sasha Bogdanovich; Kelly J Perkins; Thomas O B Krag; Tejvir S Khurana
Journal:  J Mol Med (Berl)       Date:  2003-12-12       Impact factor: 4.599

7.  Mdx muscle grafts retain the mdx phenotype in normal hosts.

Authors:  J E Morgan; G R Coulton; T A Partridge
Journal:  Muscle Nerve       Date:  1989-05       Impact factor: 3.217

8.  Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles.

Authors:  Massimiliano Cerletti; Sara Jurga; Carol A Witczak; Michael F Hirshman; Jennifer L Shadrach; Laurie J Goodyear; Amy J Wagers
Journal:  Cell       Date:  2008-07-11       Impact factor: 41.582

9.  Myoblast transfer in the treatment of Duchenne's muscular dystrophy.

Authors:  J R Mendell; J T Kissel; A A Amato; W King; L Signore; T W Prior; Z Sahenk; S Benson; P E McAndrew; R Rice
Journal:  N Engl J Med       Date:  1995-09-28       Impact factor: 91.245

View more
  1 in total

1.  AMP-activated protein kinase α1 but not α2 catalytic subunit potentiates myogenin expression and myogenesis.

Authors:  Xing Fu; Jun-Xing Zhao; Mei-Jun Zhu; Marc Foretz; Benoit Viollet; Mike V Dodson; Min Du
Journal:  Mol Cell Biol       Date:  2013-09-16       Impact factor: 4.272

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.